FDAnews Device Daily Bulletin

PierianDx Acquires Tute Genomics

Oct. 13, 2016

PierianDx has acquired of Tute Genomics, which furthers PierianDx’s goal to become a comprehensive, integrated platform to enable personalized medicine for clinical labs.

As part of the deal, Reid Robison, CEO of Tute, will join the PierianDx board of directors, and Tute COO Andy Olson and Vice President of Product Development Bryce Daines will relocate to St. Louis, where PierianDx is based.

The PierianDx and Tute Genomics platforms will be fully integrated in the spring of 2017, PierianDx said. — Cynthia Jessup

View today's stories